无高危HLA-DR4-DQ8或HLA-DR3-DQ2单倍型的自身抗体阳性个体的特征
研究将1型糖尿病患者的自身抗体阳性亲属按HLA单倍型分为四组,比较人口学、代谢指标及自身抗体阳性率。结果表明缺乏两种高危单倍型的DRX/DRX组和DR3/non-DR4组与DR3/DR4及DR4/non-DR3组存在表型差异,提示1型糖尿病存在病因异质性。
要点
- DRX/DRX组IA-2A阳性率20.9%,低于DR4/non-DR3组的38.5%和DR3/DR4组的44.8%(均p<0.001),与DR3/non-DR4组的20.0%相似。
- DR3/non-DR4组IAA阳性率30.1%,低于DRX/DRX组的43.4%、DR4/non-DR3组的41.1%和DR3/DR4组的41.0%(p<0.001)。
- 在进展为临床1型糖尿病的1292例中,DR3/non-DR4组GADA阳性率高于其他组、IA-2A和IAA阳性率低于其他组(均p<0.01),DR3/DR4组诊断年龄最小(p<0.001)。
核心结论
- 缺乏两种高危HLA单倍型的DRX/DRX个体或具有HLA-DR3-DQ2但缺乏HLA-DR4-DQ8的DR3/non-DR4个体,与DR3/DR4和DR4/non-DR3个体相比存在表型差异,提示1型糖尿病存在病因异质性。
研究设计与样本
- 研究纳入1型糖尿病患者的自身抗体阳性亲属,按HLA单倍型分为四组:同时具有HLA-DR4-DQ8和HLA-DR3-DQ2(DR3/DR4,n=1263)、具有HLA-DR4-DQ8但无HLA-DR3-DQ2(DR4/non-DR3,n=2340)、具有HLA-DR3-DQ2但无HLA-DR4-DQ8(DR3/non-DR4,n=1607)以及两者均无(DRX/DRX,n=1294)。
- 比较入组时的人口学特征、代谢标志物及针对GAD65(GADA%)、IA-2(IA-2A%)或胰岛素(IAA%)的自身抗体阳性率,p<0.01认为有统计学显著性。
主要发现
- DRX/DRX组IA-2A%为20.9%,低于DR4/non-DR3组的38.5%(p<0.001)和DR3/DR4组的44.8%(p<0.001),与DR3/non-DR4组的20.0%相似。
- DRX/DRX组IAA%为43.4%,与DR4/non-DR3组的41.1%和DR3/DR4组的41.0%相似,但DR3/non-DR4组IAA%为30.1%,低于上述三组(p<0.001)。
- DRX/DRX组较DR3/DR4组年龄更大、白人比例更低、超重/肥胖比例更高、Index60更低(均p<0.005);较DR4/non-DR3组白人或非西班牙裔比例更低、Index60更低;较DR3/non-DR4组年龄更小、西班牙裔比例更高、Index60更低(均p<0.005)。
- 在1292例进展为临床1型糖尿病的参与者中,DR3/non-DR4组GADA%高于其他组、IA-2A%和IAA%低于其他组(均p<0.01),DR3/DR4组诊断年龄最小(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Many studies of type 1 diabetes pathogenesis focus on individuals with high-risk HLA haplotypes. We tested the hypothesis that, among islet autoantibody-positive individuals, lacking HLA-DRB1*04-DQA1*03-DQB1*0302 (HLA-DR4-DQ8) and/or HLA-DRB1*0301-DQA1*0501-DQB1*0201 (HLA-DR3-DQ2) is associated with phenotypic differences, compared with those who have these high-risk HLA haplotypes. METHODS: We classified autoantibody-positive relatives of individuals with type 1 diabetes into four groups based on having both HLA-DR4-DQ8 and HLA-DR3-DQ2 (DR3/DR4; n=1263), HLA-DR4-DQ8 but not HLA-DR3-DQ2 (DR4/non-DR3; n=2340), HLA-DR3-DQ2 but not HLA-DR4-DQ8 (DR3/non-DR4; n=1607) and neither HLA-DR3-DQ2 nor HLA-DR4-DQ8 (DRX/DRX; n=1294). Group comparisons included demographics, metabolic markers and the prevalence of autoantibodies against GAD65 (GADA%), IA-2 (IA-2A%) or insulin (IAA%) at enrolment. A p value <0.01 was considered statistically significant. RESULTS: IA-2A% was lower in the DRX/DRX group (20.9%) than in the DR4/non-DR3 (38.5%, p<0.001) and DR3/DR4 (44.8%, p<0.001) groups, but similar to the DR3/non-DR4 group (20.0%). Conversely, IAA% was similar in the DRX/DRX (43.4%), DR4/non-DR3 (41.1%) and DR3/DR4 (41.0%) groups, but lower in the DR3/non-DR4 group (30.1%, p<0.001). Participants in the DRX/DRX group were older, with a lower prevalence of White participants and a higher prevalence of overweight/obesity, and higher preserved C-peptide (as measured by a lower Index60) than those in the DR3/DR4 group (all comparisons, p<0.005), a lower prevalence of White or non-Hispanic participants and a lower Index60 than those in the DR4/non-DR3 group, and younger age, a higher prevalence of Hispanic participants and a lower Index60 than those in the DR3/non-DR4 group (all comparisons, p<0.005). Among the 1292 participants who progressed to clinical type 1 diabetes, those in the DR3/non-DR4 group had higher GADA%, lower IA-2A% and lower IAA% than the other groups (all comparisons, p<0.01), and those in the DR3/DR4 group had the youngest age at diagnosis (all comparisons, p<0.001). CONCLUSIONS/INTERPRETATION: Autoantibody-positive individuals who lack both high-risk HLA haplotypes (DRX/DRX) or have HLA-DR3-DQ2 but lack HLA-DR4-DQ8 (DR3/non-DR4) have phenotypic differences compared with DR3/DR4 and DR4/non-DR3 individuals, suggesting that there is aetiological heterogeneity in type 1 diabetes.
引用
- Redondo MJ, Cuthbertson D, Steck AK, et al. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2024. PMID: 39670998. doi:10.1007/s00125-024-06338-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。